Quest PharmaTech Inc's stock has seen significant volatility this week, closing at C$0.02.
Quest PharmaTech Inc (QPT.V) has experienced a notable decline in its stock performance this week, down 33.33%. This follows a trend of underperformance year-to-date, with shares down 42.86%. Despite a stable closing price of C$0.02, the company has not released any significant news to explain this movement.
Advertisement
Quest PharmaTech Inc
QPT.V
QPT.V
Quest PharmaTech Inc
WealthAwesomeMarket cap
$3.38M
P/E
0.7x
52W high
$0.05
52W low
$0.02
1W change
-33.33%
Beta
-0.46
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on QPT's historical volatility
30-Day Vol
252.9%
Annualized
90-Day Vol
224.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.05 |
| 60 trading days | C$0.02 | C$0.01 – C$0.06 |
| 90 trading days | C$0.02 | C$0.00 – C$0.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should note the lack of recent company news and the stock's low trading volume, which may suggest limited investor interest or confidence at this time.
Quest PharmaTech Inc's stock down 33.33% this week.
The stock's trading volume was only 11% of its 20-day average, indicating low investor activity.
Bull case
Quest PharmaTech has a low price-to-earnings ratio of 0.6667 and a return on equity of 20.0%. This could mean the stock is undervalued, especially if positive developments occur in the future.
Bear case
The significant drop in stock price and low trading volume raise concerns about the company’s market presence and investor confidence, suggesting potential volatility ahead.
Recent Price Action
Advertisement
Quest PharmaTech Inc's stock closed at C$0.02, reflecting no change in the last trading session. However, the stock has seen a significant decline of 33.33% over the past week, which raises concerns about its performance amidst a year-to-date drop of 42.86%. The current price sits at the lower end of its 52-week range of C$0.02 to C$0.05.
Technical Picture
The technical indicators paint a cautious picture for Quest PharmaTech. The stock is currently trading below both its 50-day moving average of C$0.02 and its 200-day moving average of C$0.03, indicating a bearish trend. With a beta of -0.46, the stock tends to be less volatile compared to the broader market. The trading volume has also been low, with only 4,000 shares changing hands compared to the 20-day average of 37,296 shares, suggesting a lack of investor interest.
Insider Activity
No recent insider activity has been reported for Quest PharmaTech, which may indicate a lack of confidence from insiders about the company's near-term prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
